Extract

The purpose of this study is to assess the biological safety and efficacy of using the drug, C2L-OCT-01 PR, 30 mg to treat acromegalic patients.

Inclusion criteria

• Acromegaly

Country

• Belarus
• Hungary
• Romania
• Serbia
• Slovakia
• Ukraine

Links

• ictrp
• nct